0000950170-24-041787.txt : 20240404 0000950170-24-041787.hdr.sgml : 20240404 20240404160005 ACCESSION NUMBER: 0000950170-24-041787 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240402 FILED AS OF DATE: 20240404 DATE AS OF CHANGE: 20240404 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Awad Antoine CENTRAL INDEX KEY: 0001820122 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37566 FILM NUMBER: 24823069 MAIL ADDRESS: STREET 1: C/O SYNLOGIC, INC. STREET 2: 301 BINNEY STREET, SUITE 402 CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SYNLOGIC, INC. CENTRAL INDEX KEY: 0001527599 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 261824804 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 301 BINNEY STREET STREET 2: SUITE 402 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-401-9975 MAIL ADDRESS: STREET 1: 301 BINNEY STREET STREET 2: SUITE 402 CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Mirna Therapeutics, Inc. DATE OF NAME CHANGE: 20110809 4 1 ownership.xml 4 X0508 4 2024-04-02 0001527599 SYNLOGIC, INC. SYBX 0001820122 Awad Antoine C/O SYNLOGIC, INC. 301 BINNEY STREET, SUITE 402 CAMBRIDGE MA 02142 false true false false Chief Operating Officer false Common Stock 2024-04-02 4 S false 372 1.73 D 33859 D Represents the number of shares sold by the reporting person on April 2, 2024 to cover the tax liability in connection with the vesting of three restricted stock awards, vesting on April 1, 2024, that were granted in 2020, 2021 and 2022. /s/ Antoine Awad 2024-04-04